L’Europa più sana grazie all’omeopatia

Dichiarazione del Comitato Europeo per l’Omeopatia (ECH)
e della Federazione Europea delle Associazioni di Pazienti Omeopatici (EFHPA)

L’omeopatia fornisce delle soluzioni ai principali problemi sanitari dei Paesi d’Europa

  • L’omeopatia aiuta a ridurre la necessità di antibiotici nell’assistenza sanitaria umana e veterinaria, riducendo così il problema della resistenza antimicrobica. 1,2
  • L’omeopatia, se integrata nell’assistenza sanitaria, aumenta la qualità della vita e riduce la gravità dei reclami nei pazienti con malattia cronica. 3,4,5,6,7,8
  • L’omeopatia, se integrata nell’assistenza sanitaria, può ridurre l’uso di farmaci da prescrizione convenzionali a lungo termine. 9

L’omeopatia soddisfa meglio il paziente ed è sicura ed economica

  • Il trattamento omeopatico, se integrato nell’assistenza sanitaria, permette di ridurre i costi terapeutici. 10,11,12
  • Il trattamento omeopatico è sicuro, con alta soddisfazione del paziente. 13,14,15,16
  • I pazienti che seguono un trattamento omeopatico hanno risultati superiori rispetto ai pazienti in trattamento convenzionale, con costi simili. 17
  • La qualità, la sicurezza e la corretta etichettatura dei prodotti omeopatici è garantita dalla Direttiva 2001/83 CE.

I consumatori Europei chiedono che l’Omeopatia sia integrata nella loro assistenza sanitaria

  • L’omeopatia è considerata la medicina complementare più utilizzata in Europa. 18
  • Tre cittadini europei su quattro stanno già fatto uso dell’omeopatia e di essi il 29% la utilizza per le proprie cure quotidiane. 19

Prove scientifiche di altissimo livello confermano l’efficacia clinica della medicina omeopatica

  • Gli effetti clinici dei medicinali omeopatici sono stati confermati da numerose revisioni sistematiche e da metanalisi. 20,21,22,23,24,25,26

Esistono prove convincenti dell’efficacia biologica della medicina omeopatica

  • Sono state pubblicate prove scientifiche inconfutabili, osservate in laboratorio, degli effetti di sostanze preparate seguendo il metodo omeopatico. 27,28

 

Bibliografia

  1. Grimaldi-Bensouda L, Bégaud B, Rossignol M, et al. Management of upper respiratory tract infections by different medical practices, including homeopathy, and consumption of antibiotics in primary care: the EPI3 cohort study in France 2007-2008. PLoS One. 2014 Mar 19;9(3):e89990.
  2. Camerlink I, Ellinger L, Bakker EJ, Lantinga EA. Homeopathy as replacement to antibiotics in the case of Escherichia coli diarrhoea in neonatal piglets. 2010 Jan;99(1):57-62.
  3. Witt CM, Lüdtke R, Baur R, Willich SN. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health 2005;5:115.
  4. Spence DS, Thompson EA, Barron SJ. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. J Altern Complement Med 2005;11:793-798.
  5. Mathie RT, Robinson TW. Outcomes from homeopathic prescribing in medical practice: a prospective, research-targeted, pilot study. Homeopathy 2006;95:199-205.
  6. Thompson EA, Mathie RT, Baitson ES, et al. Towards standard setting for patient-reported outcomes in the NHS homeopathic hospitals. Homeopathy 2008;97:114-121.
  7. Witt CM, Lüdtke R, Mengler N, Willich SN. How healthy are chronically ill patients after eight years of homeopathic treatment?–Results from a long term observational study BMC Public Health 2008;8:413.
  8. Rossi E, Endrizzi C, Panozzo MA, Bianchi A, Da Frè M. Homeopathy in the public health system: a seven-year observational study at Lucca Hospital (Italy). Homeopathy 2009;98:142-148.
  9. Grimaldi-Bensouda L, Abenhaim L, Massol J, et al. EPI3-LA-SER group. Homeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort study. BMC Complement Altern Med. 2016 May 4;16:125.
  10. Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ. 2012 Dec;13(6):769-76.
  11. Baars EW, Kooreman P. A 6-year comparative economic evaluation of healthcare costs and mortality rates of Dutch patients from conventional and CAM GPs. BMJ Open. 2014 Aug 27;4(8):e005332.
  12. Colas A, Danno K, Tabar C, Ehreth J, Duru G. Economic impact of homeopathic practice in general medicine in France. Health Econ Rev. 2015;5(1):55.
  13. Van Wassenhoven M, Galen Y. An observational study of patients receiving homeopathic treatment. Homeopathy 2004 Jan;93(1):3-11.
  14. Marian F, Joost K, Saini KD, von Ammon K, Thurneysen A, Busato A. Patient satisfaction and side effects in primary care: An observational study comparing homeopathy and conventional medicine. BMC Complement Altern Med. 2008 Sep 18;8:52.
  15. Witt C, Keil T, Selim D, et al. Outcome and costs of homoeopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders. Complement Ther Med. 2005;13(2):79-86.
  16. Marian F, Joost K, Saini KD, von Ammon K, Thurneysen A, Busato A. Patient satisfaction and side effects in primary care: An observational study comparing homeopathy and conventional medicine. BMC Complement Altern Med. 2008 Sep 18;8:52.
  17. Bornhöft G, Wolf U, von Ammon K, Righetti M, Maxion-Bergemann S, Baumgartner S, Thurneysen AE, Matthiessen PF. Effectiveness, safety and cost-effectiveness of homeopathy in general practice – summarized health technology assessment.Forsch Komplementmed. 2006;13 Suppl 2:19-29. Epub 2006 Jun 26. Review.
  18. Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos K Ͳ Rey, Vas J, von Ammon K, Hegyi G, Dragan S, Uehleke B, Fønnebø V, Lewith G. CAM use in Europe. The patients’ perspective.Part I: A systematic literature review of CAM prevalence in the EU. 2012. Online retrieved 19-11-2019. https://cam-europe.eu/wp-content/uploads/2018/09/CAMbrella-WP4-part_1final.pdf.
  19. Report of the European Commission, 1997. Online retrieved 15-12-2019 via https://www.hri-research.org/resources/essentialevidence/use-of-homeopathy-across-the-world/.
  20. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet. 1997 Sep 20;350(9081):834-4.
  21. Cucherat M, Haugh MC, Gooch M, Boissel JP.Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group. Eur J Clin Pharmacol. 2000 Apr;56(1):27-33.
  22. Hahn RG. Homeopathy: meta-analyses of pooled clinical data. Forsch Komplementmed. 2013;20(5):376-81.
  23. Mathie RT, Van Wassenhoven M, Jacobs J et al. Model validity and risk of bias in randomised placebo-controlled trials of individualised homeopathic treatment. Complement Ther Med. 2016 Apr;25:120-5.
  24. Mathie RT, Lloyd, SM, Legg, LA, Clausen J, Moss S, Davidson JR, Ford : Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev 2014 Dec 6;3:142.
  25. Mathie RT, Clausen J. Veterinary homeopathy: systematic review of medical conditions studied by randomised placebo-controlled trials. Vet Rec. 2014 Oct 18;175(15):373-81.
  26. Mathie RT, Clausen J. Veterinary homeopathy: meta-analysis of randomised placebo-controlled trials. Homeopathy. 2015 Jan;104(1):3-8.
  27. Tournier A, Klein SD, Würtenberger S, Wolf U, Baumgartner S. Physicochemical Investigations of Homeopathic Preparations: A Systematic Review and Bibliometric Analysis-Part 2. J Altern Complement Med. 2019 Jul 10.
  28. Witt CM, Bluth M, Albrecht H, Weisshuhn TE, Baumgartner S, Willich SN. The in vitro evidence for an effect of high homeopathic potencies–a systematic review of the literature. Complement. Ther Med. 2007 Jun;15(2):128-38.

Per scaricare il pdf del documento >>> cliccare qui

Lascia un commento